Qube Research & Technologies Ltd - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$5,016
-99.6%
56
-99.6%
0.00%
-100.0%
Q2 2023$1,133,128
-12.9%
13,309
-15.3%
0.00%
-33.3%
Q1 2023$1,300,499
-58.3%
15,716
-60.3%
0.01%
-64.7%
Q4 2022$3,115,562
+72.9%
39,613
+62.8%
0.02%
+54.5%
Q3 2022$1,802,000
+16.8%
24,335
+2.8%
0.01%0.0%
Q2 2022$1,543,000
-46.2%
23,670
-8.4%
0.01%
-75.6%
Q1 2021$2,867,000
-9.1%
25,827
-26.7%
0.04%
-2.2%
Q2 2020$3,155,000
+1302.2%
35,224
+1702.7%
0.05%
+557.1%
Q4 2019$225,000
-12.5%
1,954
-8.5%
0.01%
-88.5%
Q2 2019$257,000
+29.1%
2,135
+23.1%
0.06%
+134.6%
Q3 2018$199,000
+397.5%
1,735
+293.4%
0.03%
+4.0%
Q2 2018$40,0004410.02%
Other shareholders
HAEMONETICS CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders